Tenn. Comp. R. & Regs. 0400-20-07-.48 - TRAINING FOR THE ORAL ADMINISTRATION OF SODIUM IODINE I-131 REQUIRING A WRITTEN DIRECTIVE IN QUANTITIES LESS THAN OR EQUAL TO 122 GIGABECQUERELS (33 MILLICURRIES)

(1) Except as provided in Rule 0400-20-07-.26, a licensee shall require an authorized user for the oral administration of sodium iodide I-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (33 millicuries), to be a physician who:
(a) Is certified by a medical specialty board whose certification process includes all of the requirements in subparagraph (c) of this paragraph and whose certification has been recognized by the Division, the U.S. Nuclear Regulatory Commission or an Agreement State and who meets the requirements in part (c)3 of this paragraph; (The names of board certifications which have been recognized by the U.S. Nuclear Regulatory Commission or an Agreement State will be posted on the U.S. Nuclear Regulatory Commission's Web page); or
(b) Is an authorized user under Rule 0400-20-07-.47 for uses listed in subitem (1)(b)1(ii)(VI)I or II of Rule 0400-20-07-.47, Rule 0400-20-07-.49, or equivalent Agreement State or U.S. Nuclear Regulatory Commission requirements; or
(c)
1. Has successfully completed 80 hours of classroom and laboratory training , applicable to the medical use of sodium iodide I-131 for procedures requiring a written directive. The training must include:
(i) Radiation physics and instrumentation;
(ii) Radiation protection;
(iii) Mathematics pertaining to the use and measurement of radioactivity;
(iv) Chemistry of radioactive material for medical use; and
(v) Radiation biology; and
2. Has work experience, under the supervision of an authorized user who meets the requirements in Rule 0400-20-07-.26, 0400-20-07-.47, 0400-20-07-.48, 0400-20-07-.49, or equivalent Agreement State or U.S. Nuclear Regulatory Commission requirements. A supervising authorized user who meets the requirements in subparagraph (1)(b) of Rule 0400-20-07-.47, must also have experience in administering dosages as specified in subitem (1)(b)1(ii)(VI)I or II of Rule 0400-20-07-.47. The work experience must involve:
(i) Ordering, receiving, and unpacking radioactive materials safely and performing the related radiation surveys;
(ii) Performing quality control procedures on instruments used to determine the activity of dosages and performing checks for proper operation of survey meters; .
(iii) Calculating, measuring, and safely preparing patient or human research subject dosages;
(iv) Using administrative controls to prevent a misadministration involving the use of radioactive material;
(v) Using procedures to contain spilled radioactive material safely and using proper decontamination procedures; and
(vi) Administering dosages to patients or human research subjects, that includes at least 3 cases involving the oral administration of less than or equal to 1.22 gigabecquerels (33 millicuries) of sodium iodide I-131; and
3. Has obtained written attestation that the individual has satisfactorily completed the requirements in parts 1 and 2 of this subparagraph and has achieved a level of competency sufficient to function independently as an authorized user for medical uses authorized under Rule 0400-20-07-.44. The written attestation must be signed by a preceptor authorized user who meets the requirements in Rule 0400-20-07-.26, 0400-20-07-.47, 0400-20-07-.48, 0400-20-07-.49, or equivalent Agreement State or U.S. Nuclear Regulatory Commission requirements. A preceptor authorized user, who meets the requirement in subparagraph (1)(b) of Rule 0400-20-07-.47, must also have experience in administering dosages as specified in subitem (1)(b)1(ii)(VI)I or II of Rule 0400-20-07-.47.

Notes

Tenn. Comp. R. & Regs. 0400-20-07-.48
Original rule filed February 22, 2012; effective May 22, 2012.

Authority: T.C.A. ยงยง 68-202-101 et seq., 68-202-201 et seq. and 4-5-201 et seq.

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.


No prior version found.